Hong Kong stock anomaly | Silver Noah Pharmaceuticals-B (02591.HK) rose more than 6%, will report the clinical research data of Icosapentethylglucose China IIb phase at ADA 2026 conference

According to the China Securities App, Yunuo Pharmaceutical-B (02591.HK) rose more than 6%, as of press time, up 5.79% to 10.62 Hong Kong dollars, with a turnover of 90.3299 million Hong Kong dollars.